Virpax Pharmaceuticals, Inc.
VRPX
$0.02
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8,697.09% | -99.08% | 0.25% | -79.59% | -24.78% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -11.24% | -92.48% | -21.97% | 272.68% | -53.43% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -97.53% | -1.95% | -74.68% | 78.51% | -36.80% |
| Total Current Assets | 411.37% | -88.26% | -17.24% | -67.49% | -26.15% |
|
|
|||||
| Total Current Assets | 411.37% | -88.26% | -17.24% | -67.49% | -26.15% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 411.37% | -88.26% | -17.24% | -67.49% | -26.15% |
|
|
|||||
| Total Accounts Payable | -57.32% | 27.72% | 466.92% | -28.11% | -44.28% |
| Total Accrued Expenses | 7.47% | -19.58% | 53.49% | 9.24% | 11.74% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | 0.00% | -58.33% | 20.00% |
| Total Other Current Liabilities | -- | -- | 0.00% | -58.33% | 20.00% |
| Total Current Liabilities | 4.82% | -56.25% | 23.97% | -43.54% | 17.78% |
|
|
|||||
| Total Current Liabilities | 4.82% | -56.25% | 23.97% | -43.54% | 17.78% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.82% | -56.25% | 23.97% | -43.54% | 17.78% |
|
|
|||||
| Common Stock & APIC | 6.84% | 4.34% | 3.04% | 0.12% | -0.02% |
| Retained Earnings | -4.97% | -3.03% | -5.50% | -5.41% | -8.30% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 55.46% | 26.58% | -130.30% | -162.73% | -70.27% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 55.46% | 26.58% | -130.30% | -162.73% | -70.27% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 55.46% | 26.58% | -130.30% | -162.73% | -70.27% |
|
|
|||||